CapsoVision, Inc.
CV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$363.43M
Close$
$-2.17
131.8% downside
Current Fair Value
131.8% downsideOvervalued by 131.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $363.43 Million |
|---|---|
| Enterprise Value | $355.18 Million |
| Earnings per Share | $-0.54 |
| Beta | -2.46 |
| Outstanding Shares | 49,937,525 |
Return
| Return on Equity | -226.56% |
|---|---|
| Return on Assets | -160.64% |
| Return on Invested Capital | -150.08% |
Valuation & Multiples
| P/E Ratio | -10.84 |
|---|---|
| PEG | -17.56 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 25.57 |
| Enterprise Value to EBIT | -17.65 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.13
Consensus analyst estimateRevenue Estimate
$3.81 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.15
Consensus analyst estimateRevenue Estimate
$3.74 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.36%▲ 1.95% |
|---|---|
| Total Invested | $39.23M▲ 34.72% |
| Investors Holding | 52▲ 2.00% |
About CapsoVision, Inc.
90 employees
CEO: Kang Huai Wang
Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics